• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

ART signs GE

Article

GE Medical Systems has agreed to distribute a preclinical optical molecular imaging system made by Advanced Research Technologies. The deal grants GE exclusive worldwide rights to distribute the system, called SAMITM, which is designed for use in the R&D

GE Medical Systems has agreed to distribute a preclinical optical molecular imaging system made by Advanced Research Technologies. The deal grants GE exclusive worldwide rights to distribute the system, called SAMITM, which is designed for use in the R&D of therapeutic and diagnostic drugs. The system is an optical fluorescence molecular imaging device designed to help pharmaceutical companies and research laboratories better understand disease and shorten the development cycle for new drugs. The technology is based on ART's proprietary time domain optical imaging technology, which noninvasively images tissue to reveal the biological distribution and concentration of fluorescence-labeled markers. GE holds an equity stake in the firm and is advising staff there on the development of clinical products based on the optical technology (SCAN 11/6/02).

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
© 2025 MJH Life Sciences

All rights reserved.